Login

Israel Englander is the founder and CEO of Millennium Management, a leading hedge fund in the USA. 00:10:00

Share On Facebook Share On Twitter

Israel Englander is Chairman and Chief Executive Officer of Millennium

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Minco Gold Explores Rapid Growth Opportunities at One-to-One Mining Conference
00:10:00
Scale needs to be achieved quickly but also correctly|Roseanne Wincek,Co-Founder and Managing Director,Renegade Partners
00:10:00
Bloomberg Talks with Ranesh Ramanathan: Banks Forge New Paths into Direct Lending Arena | Ranesh Ramanathan - Partner, akin gump strauss hauer & feld llp
00:10:00
Assessing Market Complacency and Monetary Policy Uncertainty |Sergio Ermotti, CEO , UBS.
00:10:00
Birimian Lithium Project Financing Strategy
00:10:00
Fuad Ajami on Iraq's Impact and Regional Dynamics
00:10:00
Tim Chen, CEO of NerdWallet, appears on 'Closing Bell Overtime' to discuss quarterly results, the lending environment, and more.|Tim Chen is the founder and CEO of NerdWallet.
00:10:00
Vetrya Spa CEO Luca Tomassini Speaks at Glocal Economic Forum ESG89 | Luca Tomassini, Ceo of Vetrya Spa
00:10:00
Introducing M1's Owner's Rewards Credit Card: A Unique Integration of Spending and Investing
00:10:00
Azimut's Strategic Vision | Paolo Martini, CEO , Azimut Holding.
00:10:00
Managing Backdoor Roth Contributions and IRA Conversions: Key Tax Considerations | Rebecca Conner, Founder, SeedSafe Financial LLC.
00:10:00
2023 Outlook for Australia's Oil and Gas: Insights with Managing Director Ian Lusted

© 2017 - Neuhu+